A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers

Clinical trial NCT03541044 · COMPLETED

Trial details

NCT number: NCT03541044
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tobacco Use Disorder

Start date: 2018-06-18
Primary completion: 2019-03-24
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.